RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
A giant leap in drug discovery. New molecule selection to evaluation in 46 days using deep generative model. Genentech took 8 years to do the same. Generative tensorial reinforcement learning (GENTRL) is brand new but promising. https://t.co/Vk4bJTWshC
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @MrJeffKarp: Deep learning enables rapid identification of potent DDR1 kinase inhibitors - a kinase target implicated in fibrosis and ot…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors - a kinase target implicated in fibrosis and other diseases, in 21 days https://t.co/T5xLFkfTf9
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @Karolien1231: @frankkumli @FrankPonsaert @Karolien1231 @dr_wardsam @B_Hf_T @numerikare @HealthBuzzBE @giovbriganti Real time data & de…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @nob_mai: 香港のベンチャー企業Insilico Medicineから Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/Mq6gP9g…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
Deep learning enables rapid identification of potent DDR1 kinase inhibitorsDeep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/5e0odhnWXV
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @hlcao: 21days. Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/xPRzBfML…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @nob_mai: 香港のベンチャー企業Insilico Medicineから Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/Mq6gP9g…
すげー データベースで探して(ここは出来る) 構造から類推して(出来ない) プライオリティ決めて(出来ない) 合成予想して(出来るわけがない) しかも進化予想?
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @nob_mai: 香港のベンチャー企業Insilico Medicineから Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/Mq6gP9g…
香港のベンチャー企業Insilico Medicineから Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/Mq6gP9gGAY
“Deep learning enables rapid identification of potent DDR1 kinase inhibitors” https://t.co/rljeuxaCnV
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
21days. Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/xPRzBfMLTV
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @Karolien1231: @frankkumli @FrankPonsaert @Karolien1231 @dr_wardsam @B_Hf_T @numerikare @HealthBuzzBE @giovbriganti Real time data & de…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
オモロー
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/dGLTYPQUMO
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @ElementoLab: First ever demonstration that AI can generate entirely novel, synthesizable, active molecules against specific pharmacolog…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
論文とかで表に出てこないAI創薬の産業側の人達は何をやっているのか。
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
Great post by @EricTopol Every day, we are reminded that #AI is not the solution to all of problems (which is true). But it is definitely the solution to A LOT OF our problems such as #enhanced #drugdiscovery #nature
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @ElementoLab: First ever demonstration that AI can generate entirely novel, synthesizable, active molecules against specific pharmacolog…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @DeepTech_VC: Our Portfolio Company @InSilicoMeds made an unprecedented #scientific breakthrough ! This is an AlphaGo moment for the wh…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @DK_Analytics: Deep Knowledge Ventures's Portfolio Company @InSilicoMeds made an unprecedented #scientific breakthrough ! This is an Al…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @aubreydegrey: Insilico publishes GENTRL. They use GAN-RL technology to collaborate with the leading longevity companies including Juven…
RT @HartungIngo: A new case study about deep learning in drug discovery @NatureBiotech: in 7 weeks to potent, cell active & lead-like DDR1…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…